Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials

Autologous bone marrow mononuclear cell (BM-MNC) therapy for patients with ST-segment elevation myocardial infarction (STEMI) has produced inconsistent results, possibly due to BM-MNC product heterogeneity. Patient-specific cardiovascular risk factors (CRFs) may contribute to variations in BM-MNC co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Basic Res Cardiol
Autores principales: Contreras, Ariadna, Orozco, Aaron F., Resende, Micheline, Schutt, Robert C., Traverse, Jay H., Henry, Timothy D., Lai, Dejian, Cooke, John P., Bolli, Roberto, Cohen, Michelle L., Moyé, Lem, Pepine, Carl J., Yang, Phillip C., Perin, Emerson C., Willerson, James T., Taylor, Doris A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760218/
https://ncbi.nlm.nih.gov/pubmed/27882430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00395-016-0592-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares